[Clinical trials with stem cells in digestive diseases and future perspectives]
1Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. taeilkim@yuhs.ac
Summary
Stem cell therapy shows promise for refractory digestive diseases like Crohn's disease and liver cirrhosis by reducing inflammation and regenerating tissue. Further research is needed to optimize treatments and address technical challenges for widespread clinical application.
Area of Science:
- Digestive regenerative medicine
- Stem cell biology
- Gastroenterology
Background:
- Rapid advancements in stem cell isolation, expansion, and handling techniques.
- Preclinical evidence suggests stem cell therapy's potential for treating refractory diseases.
- Digestive diseases like Crohn's disease and liver cirrhosis are key targets for stem cell applications.
Purpose of the Study:
- To review the current status and future potential of stem cell therapy for refractory digestive diseases.
- To highlight the application of stem cells in managing Crohn's disease and liver cirrhosis.
- To identify areas requiring further research for practical stem cell therapy development.
Main Methods:
- Review of preclinical evidence and ongoing clinical trials.
- Focus on hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) from various sources.
- Consideration of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs).
Main Results:
- Clinical trials using HSCs and MSCs show benefits in immune modulation, inflammation suppression, and cell regeneration for Crohn's disease and liver cirrhosis.
- Evidence suggests stem cell therapy can aid in anti-inflammation and tissue regeneration.
- Ongoing research explores various stem cell types and their therapeutic potential.
Conclusions:
- Stem cell therapy holds significant promise for treating refractory digestive diseases.
- Further investigation into underlying mechanisms, optimal stem cell populations, sources, and monitoring parameters is crucial.
- Technical challenges must be overcome for the successful clinical translation of stem cell therapies in digestive regenerative medicine.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:23Renewal of Intestinal Stem Cells
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...